<!DOCTYPE html>
<html lang="" xml:lang="">
<head>

<meta charset="utf-8" />
<meta name="generator" content="pandoc" />
<meta name="viewport" content="width=device-width, initial-scale=1" />
<meta property="og:title" content="Summary |  97039 - GLOBAL HEALTH, ANTIMICROBIAL DRUGS AND VACCINES" />
<meta property="og:type" content="book" />





<meta name="author" content="Russell E. Lewis, Associate Professor, Infectious Diseases, Department of Medical and Surgical Sciences" />

<meta name="date" content="2022-11-26" />

<script type="text/x-mathjax-config">
MathJax.Hub.Config({
  TeX: { equationNumbers: { autoNumber: "AMS" } }
});
</script>
  <script src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-chtml-full.js" type="text/javascript"></script>

<meta name="description" content="Summary |  97039 - GLOBAL HEALTH, ANTIMICROBIAL DRUGS AND VACCINES">

<title>Summary |  97039 - GLOBAL HEALTH, ANTIMICROBIAL DRUGS AND VACCINES</title>

<script src="libs/header-attrs-2.11/header-attrs.js"></script>
<script src="libs/jquery-3.6.0/jquery-3.6.0.min.js"></script>
<meta name="viewport" content="width=device-width, initial-scale=1" />
<link href="libs/bootstrap-3.3.5/css/bootstrap.min.css" rel="stylesheet" />
<script src="libs/bootstrap-3.3.5/js/bootstrap.min.js"></script>
<script src="libs/bootstrap-3.3.5/shim/html5shiv.min.js"></script>
<script src="libs/bootstrap-3.3.5/shim/respond.min.js"></script>
<style>h1 {font-size: 34px;}
       h1.title {font-size: 38px;}
       h2 {font-size: 30px;}
       h3 {font-size: 24px;}
       h4 {font-size: 18px;}
       h5 {font-size: 16px;}
       h6 {font-size: 12px;}
       code {color: inherit; background-color: rgba(0, 0, 0, 0.04);}
       pre:not([class]) { background-color: white }</style>
<script src="libs/navigation-1.1/tabsets.js"></script>




<style type="text/css">
/* Used with Pandoc 2.11+ new --citeproc when CSL is used */
div.csl-bib-body { }
div.csl-entry {
  clear: both;
}
.hanging div.csl-entry {
  margin-left:2em;
  text-indent:-2em;
}
div.csl-left-margin {
  min-width:2em;
  float:left;
}
div.csl-right-inline {
  margin-left:2em;
  padding-left:1em;
}
div.csl-indent {
  margin-left: 2em;
}
</style>

<link rel="stylesheet" href="toc.css" type="text/css" />

<style type = "text/css">
.main-container {
  max-width: 940px;
  margin-left: auto;
  margin-right: auto;
}
code {
  color: inherit;
  background-color: rgba(0, 0, 0, 0.04);
}
img {
  max-width:100%;
  height: auto;
}
/* show arrow before summary tag as in bootstrap
TODO: remove if boostrap in updated in html_document (rmarkdown#1485) */
details > summary {
  display: list-item;
  cursor: pointer;
}
</style>
</head>

<body>

<div class="container-fluid main-container">


<div class="row">
<div class="col-sm-12">
<div id="TOC">
<ul>
<li><a href="background.html#background">Background</a></li>
<li><a href="why-has-antibiotic-discovery-faltered-in-recent-years.html#why-has-antibiotic-discovery-faltered-in-recent-years">Why has antibiotic discovery faltered in recent years?</a>
<ul>
<li><a href="why-has-antibiotic-discovery-faltered-in-recent-years.html#scientific-challenges">Scientific challenges</a></li>
<li><a href="why-has-antibiotic-discovery-faltered-in-recent-years.html#antibiotic-regulatory-hurdles">Antibiotic regulatory hurdles</a></li>
</ul></li>
<li><a href="what-are-the-current-strategies-to-incentive-antibiotic-development.html#what-are-the-current-strategies-to-incentive-antibiotic-development">What are the current strategies to incentive antibiotic development?</a>
<ul>
<li><a href="what-are-the-current-strategies-to-incentive-antibiotic-development.html#antibiotic-supply-chain-problems">Antibiotic supply chain problems</a></li>
</ul></li>
<li><a href="what-can-be-done-to-ensure-antibiotic-access-in-lmics.html#what-can-be-done-to-ensure-antibiotic-access-in-lmics">What can be done to ensure antibiotic access in LMICs?</a>
<ul>
<li><a href="what-can-be-done-to-ensure-antibiotic-access-in-lmics.html#barrier-1-weak-drug-discovery-difficulties-in-market-entry-and-poor-stewardship-lead-to-irrational-selection-and-use-of-antibiotics">Barrier 1: Weak drug discovery, difficulties in market entry, and poor stewardship lead to irrational selection and use of antibiotics</a></li>
<li><a href="what-can-be-done-to-ensure-antibiotic-access-in-lmics.html#barrier-2-antibiotics-are-not-affordable-for-many-in-lmics-and-government-funding-for-health-is-low">Barrier 2: Antibiotics are not affordable for many in LMICs and government funding for health is low</a></li>
<li><a href="what-can-be-done-to-ensure-antibiotic-access-in-lmics.html#barrier-3-weak-health-systems-unreliable-supply-chains-and-poor-quality-control-fail-to-deliver-antibiotics-to-patients-in-need">Barrier 3: Weak health systems, unreliable supply chains and poor quality control fail to deliver antibiotics to patients in need</a></li>
</ul></li>
<li><a href="summary.html#summary">Summary</a></li>
</ul>
</div>
</div>
</div>
<div class="row">
<div class="col-sm-12">
<div id="summary" class="section level2 unnumbered">
<h2>Summary</h2>
<p>Ultimately, there are many interrelated factors contributing to lack of development of new antimicrobials. Although AMR cannot be eliminated, many factors can be addressed to improve the scientific and economic environment for restoring health to the antibiotic pipeline. Antibiotic stewardship and infection prevention must therefore be pursued alongside improvements in access to antibiotics in LMICs. All stakeholders—international bodies, government leaders, health and agriculture ministries, patients and medical practitioners, farmers and veterinarians, academia, and the pharmaceutical industry— must slow the emergence of resistance to existing antibiotics to ensure affordability and access everywhere.</p>
<div id="refs" class="references csl-bib-body" line-spacing="2">
<div class="csl-entry">
<div class="csl-left-margin">1. </div><div class="csl-right-inline">Bush, K. &amp; Jacoby, G. A. <a href="https://doi.org/10.1128/AAC.01009-09">Updated <span>Functional Classification</span> of <span><span class="math inline">\(\beta\)</span></span>-<span>Lactamases</span></a>. <em>Antimicrobial Agents and Chemotherapy</em> <strong>54</strong>, 969–976 (2010).</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">2. </div><div class="csl-right-inline">Livermore, D. M. <em>et al.</em> <a href="https://doi.org/10.1093/jac/dkr262">Discovery research: The scientific challenge of finding new antibiotics</a>. <em>Journal of Antimicrobial Chemotherapy</em> <strong>66</strong>, 1941–1944 (2011).</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">3. </div><div class="csl-right-inline">Payne, D. J., Gwynn, M. N., Holmes, D. J. &amp; Pompliano, D. L. <a href="https://doi.org/10.1038/nrd2201">Drugs for bad bugs: Confronting the challenges of antibacterial discovery</a>. <em>Nature reviews. Drug discovery</em> <strong>6</strong>, 29–40 (2007).</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">4. </div><div class="csl-right-inline">Kållberg, C. <em>et al.</em> <a href="https://doi.org/10.1371/journal.pone.0205166">Introduction and geographic availability of new antibiotics approved between 1999 and 2014</a>. <em>PLOS ONE</em> <strong>13</strong>, e0205166 (2018).</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">5. </div><div class="csl-right-inline">Daulaire, N., Bang, A., Tomson, G., Kalyango, J. N. &amp; Cars, O. <a href="https://doi.org/10.1111/jlme.12269">Universal <span>Access</span> to <span>Effective Antibiotics</span> is <span>Essential</span> for <span>Tackling Antibiotic Resistance</span></a>. <em>Journal of Law, Medicine &amp; Ethics</em> <strong>43</strong>, 17–21 (2015/ed).</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">6. </div><div class="csl-right-inline">Outterson, K., Orubu, E. S. F., Rex, J., Årdal, C. &amp; Zaman, M. H. Patient <span>Access</span> in 14 <span>High-Income Countries</span> to <span>New Antibacterials Approved</span> by the <span>US Food</span> and <span>Drug Administration</span>, <span>European Medicines Agency</span>, <span>Japanese Pharmaceuticals</span> and <span>Medical Devices Agency</span>, or <span>Health Canada</span>, 2010. <em>Clinical Infectious Diseases</em> ciab612 (2021) doi:<a href="https://doi.org/10.1093/cid/ciab612">10.1093/cid/ciab612</a>.</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">7. </div><div class="csl-right-inline">Wouters, O. J., McKee, M. &amp; Luyten, J. <a href="https://doi.org/10.1001/jama.2020.1166">Estimated <span>Research</span> and <span>Development Investment Needed</span> to <span>Bring</span> a <span>New Medicine</span> to <span>Market</span>, 2009-2018</a>. <em>JAMA</em> <strong>323</strong>, 844–853 (2020).</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">8. </div><div class="csl-right-inline">Echols, R., Ariyasu, M. &amp; Nagata, T. D. <a href="https://doi.org/10.1093/cid/ciz829">Pathogen-focused <span>Clinical Development</span> to <span>Address Unmet Medical Need</span>: <span>Cefiderocol Targeting Carbapenem Resistance</span></a>. <em>Clinical Infectious Diseases</em> <strong>69</strong>, S559–S564 (2019).</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">9. </div><div class="csl-right-inline">Årdal, C. <em>et al.</em> <a href="https://doi.org/10.1038/s41579-019-0293-3">Antibiotic development  economic, regulatory and societal challenges</a>. <em>Nature Reviews Microbiology</em> <strong>18</strong>, 267–274 (2020).</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">10. </div><div class="csl-right-inline">Mullard, A. <a href="https://doi.org/10.1038/d41573-019-00085-w">Achaogen bankruptcy highlights antibacterial development woes</a>. <em>Nature Reviews. Drug Discovery</em> <strong>18</strong>, 411 (2019).</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">11. </div><div class="csl-right-inline">Gotham, D. <em>et al.</em> <a href="https://doi.org/10.1016/j.healthpol.2020.11.015">Reimbursement models to tackle market failures for antimicrobials: <span>Approaches</span> taken in <span>France</span>, <span>Germany</span>, <span>Sweden</span>, the <span>United Kingdom</span>, and the <span>United States</span></a>. <em>Health Policy</em> <strong>125</strong>, 296–306 (2021).</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">12. </div><div class="csl-right-inline">Shafiq, N. <em>et al.</em> <a href="https://doi.org/10.1136/bmjgh-2021-006961">Shortage of essential antimicrobials: A major challenge to global health security</a>. <em>BMJ Global Health</em> <strong>6</strong>, e006961 (2021).</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">13. </div><div class="csl-right-inline">Do, N. T. T. <em>et al.</em> <a href="https://doi.org/10.1016/S2214-109X(21)00024-3">Community-based antibiotic access and use in six low-income and middle-income countries: A mixed-method approach</a>. <em>The Lancet Global Health</em> <strong>9</strong>, e610–e619 (2021).</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">14. </div><div class="csl-right-inline">Frost, I., Craig, J., Joshi, J., Faure, K. &amp; Laxminarayan, R. <em>Access <span>Barriers</span> to <span>Antibiotics</span></em>. (<span>Center for Disease Dynamics, Economics &amp; Policy (CDDEP)</span>, 2019).</div>
</div>
</div>
</div>
<p style="text-align: center;">
<a href="what-can-be-done-to-ensure-antibiotic-access-in-lmics.html"><button class="btn btn-default">Previous</button></a>
</p>
</div>
</div>


</div>

<script>

// add bootstrap table styles to pandoc tables
$(document).ready(function () {
  $('tr.header').parent('thead').parent('table').addClass('table table-condensed');
});

</script>

</body>
</html>
